Clorox Reports Fourth Quarter and Fiscal Year 2021 Results, Provides Fiscal Year 2022 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Clorox (CLX) Falls Sharply as COVID-19 Demand Wanes
August 3, 2021 7:59 AM EDTShares of Clorox (NYSE: CLX) are down about 10% in pre-open Tuesday after the company saw fading demand for its products.
The companys biggest unit by revenue generated, the health and wellness division, witnessed a 17% decline in sales. The company recorded falling sales in three out of four business divisions as pandemic-shaped demand for Clorox waned.
Overall, sales... More
Clorox (CLX) Misses Q4 EPS by 41c, Guidance Falls Short of Consensus
August 3, 2021 6:36 AM EDTClorox (NYSE: CLX) reported Q4 EPS of $0.95, $0.41 worse than the analyst estimate of $1.36. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.92 billion.
GUIDANCE:
Clorox sees FY2022 EPS of $5.40-$5.70, versus the consensus of $7.61.
2% to... More